TradeStation

Daily Super Summary:

Multiple reputable sources, including Reuters and CNBC, report that Akeso's experimental lung cancer drug, ivonescimab, has demonstrated significant efficacy in a late-stage clinical trial in China. The drug improved overall survival for lung cancer patients, reducing the risk of death by 34% and extending patient lifespans by 15% compared to a leading immunotherapy. These results, presented at a major oncology meeting, are supported by consistent trial data across several outlets, indicating a potentially important advancement in the treatment of lung cancer. The findings highlight the ongoing progress in oncology drug development and the potential for new therapies to outperform existing standards of care.

In addition to Akeso's breakthrough, Johnson & Johnson's prostate cancer drug Erleada has also shown promising results in a late-stage trial. When used in combination with hormone-blocking therapy before and after surgery, Erleada reduced the risk of cancer spread and death, according to data presented at a medical conference. Multiple mainstream sources confirm the consistency of these trial endpoints, underscoring the drug's potential to improve outcomes for prostate cancer patients. These developments reflect a broader trend of innovation and progress in cancer therapeutics, offering hope for improved survival rates and quality of life for patients facing serious diagnoses.

Meanwhile, the S&P 500 dividend yield has dropped to 1.08%, marking the lowest payout rate since the 1800s. This historic low, corroborated by 24/7 Wall Street and supported by historical financial data, signals a shift in the income landscape for equity investors. As companies prioritize growth and share buybacks over dividend distributions, investors seeking yield may need to reassess their strategies or look to alternative asset classes to meet their income needs in the current market environment.


Market Impact:

🔹

Justification: The news highlights major breakthroughs in oncology drug development, with both Akeso and Johnson & Johnson reporting strong, late-stage clinical trial results for cancer therapies. These advances are likely to boost sentiment in the healthcare and biotech sectors, reflecting significant progress and potential for improved patient outcomes. However, the historic drop in the S&P 500 dividend yield introduces a mild negative for income-focused investors, signaling a shift in market dynamics. On balance, the positive impact from medical innovation outweighs the negative implications of lower dividends, resulting in a mild positive overall market impact.

Legend:
🔴 = Strong Negative Impact    🔸 = Mild Negative Impact    ⚪ = Neutral    🔹 = Mild Positive Impact    🔵 = Strong Positive Impact


5/31/2026 9:02:13 AM EDT

Super Summary News is also available for:

News:

Card image cap
Can Meta Stock Reach $1,500 by 2030?

Meta Platforms (NASDAQ:META | META Price Prediction) just reported one of the strangest quarters in mega-cap tech....

24/7 Wall Street - 5/31/2026 10:38:37 AM More News for META
Stock Analysis for META

Related Stocks:

GRABAR LAW OFFICE INVESTIGATES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZOETIS, INC. (ZTS)

Philadelphia, Pennsylvania--(Newsfile Corp. - May 31, 2026) - WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Zoetis, Inc. (NYSE: ZTS)....

Newsfile Corp - 5/31/2026 10:22:00 AM More News for ZTS
Stock Analysis for ZTS

Related Stocks:

Card image cap
Card image cap
Alamos Gold: A Goldmine For Believers In Gold

Alamos Gold (AGI) is a leveraged bet on gold, offering amplified returns relative to simply holding gold, through multiple expansion. At 0.88x NAV, the stock trades at a cheap valuation relative to its mine-by-mine intrinsic value, with an upside potential even before any re-rating. With management guiding declining AISC and growing production through 2028, the company presents meaningful earnings upside even if gold prices simply sustain at current levels....

Seeking Alpha - 5/31/2026 10:17:50 AM More News for AGI
Stock Analysis for AGI

Related Stocks:

Becerra gains support in latest poll with Steyer and Hilton not far behind

Released on Saturday, the final Emerson College Polling California survey before Tuesday’s primary election found that Becerra leads the race for governor with 28%. Tom Steyer and Steve Hilton follow closely behind....

Los Angeles Times - 5/31/2026 2:24:00 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
'007: First Light' is a huge sales hit

Developer IO Interactive is seeing unprecedented success with the debut of its new 007 video game....

Mashable - 5/31/2026 2:21:09 AM More News for
Stock Analysis for

Related Stocks:

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Elauwit securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....

Newsfile Corp - 5/31/2026 10:17:00 AM More News for ELWT
Stock Analysis for ELWT

Related Stocks:

Card image cap
Card image cap
STLA FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Stellantis N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 8 Deadline in Securities Class Action - STLA

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock on the New York Stock Exchange ("NYSE") of Stellantis N.V. (NYSE: STLA) between February 26, 2025 and February 5, 2026, inclusive (the "Class Period"), of the important June 8, 2026 lead plaintiff deadline....

Newsfile Corp - 5/31/2026 10:17:00 AM More News for STLA
Stock Analysis for STLA

Related Stocks:

The Smarter Way to Invest in AI Without Taking Extreme Risk

Artificial intelligence (AI) is the trade of the decade. It turned NVIDIA NASDAQ: NVDA into a household name....

MarketBeat - 5/31/2026 10:16:35 AM More News for NVDA
Stock Analysis for NVDA

Related Stocks:

Card image cap
Card image cap
ROSEN, SKILLED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - POET

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of POET Technologies Inc. (NASDAQ: POET) between April 1, 2026 and 08:57 AM ET on April 27, 2026, inclusive (the "Class Period"), of the important June 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased POET Technologies securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....

Newsfile Corp - 5/31/2026 10:15:00 AM More News for POETF
Stock Analysis for POETF

Related Stocks:

SES AI DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages SES AI Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - SES

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SES AI Corporation (NYSE: SES) between January 29, 2025 and March 4, 2026, both dates inclusive (the "Class Period"), of the important June 26, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased SES AI securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....

Newsfile Corp - 5/31/2026 10:14:00 AM More News for SGBAF
Stock Analysis for SGBAF

Related Stocks:

Card image cap
Card image cap
The June Dog Of The Dow To Buy

Verizon stands as the only Dow stock meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by strong free cash flow. Analyst forecasts suggest top-ten Dow Dogs could deliver 17.15% to 45.09% net gains by June 2027, with an average estimated gain of 27.71%. Most Dow dividend stocks are currently overpriced, but market corrections or dividend increases could create more fair-priced buying opportunities....

Seeking Alpha - 5/31/2026 10:12:58 AM More News for DOW
Stock Analysis for DOW

Related Stocks:

CHINA CHALLENGE: Booz Allen CEO sounds alarm on AI adoption risks

Booz Allen Chairman and CEO Horacio Rozanski joins 'Mornings with Maria' to discuss the risks Chinese AI models pose to U.S. national security, combating agentic AI threats, their partnership with Anduril and more. 00:00 The AI race between the US and China 01:05 Vulnerabilities in Chinese AI models 01:45 Risks to the software supply chain 03:52 2026: The year of Agentic AI 05:03 Booz Allen's role in National Security 06:01 Partnership with Anduril and drone production...

Fox Business - 5/31/2026 10:00:39 AM More News for BAH
Stock Analysis for BAH

Related Stocks:

Card image cap
Card image cap
Inflation Is Soaring, and the Federal Reserve Could Do Something It Hasn't Done Since 2023. Here's What It Means for Stocks.

The last time inflation was this high, the S&P 500 was in a bear market....

Fool - Investing News - 5/31/2026 9:54:00 AM More News for
Stock Analysis for

Related Stocks:

Nuclear Is the Energy Story of 2026. Here Are 2 Stocks to Own All Year.

Nuclear power can benefit from the AI revolution. Two innovative nuclear stocks are positioned to benefit....

The Motley Fool - 5/31/2026 9:45:00 AM More News for OKLO
Stock Analysis for OKLO

Related Stocks:

Card image cap
Card image cap
3 Ways Kevin Warsh Aims to Reshape the Federal Reserve -- and They Can All Decimate Wall Street

Jerome Powell's successor wants to lead a reform-oriented central bank, but this can prove disastrous for the stock market....

Fool - Investing News - 5/31/2026 9:06:00 AM More News for
Stock Analysis for

Related Stocks:

Greg Abel Just Dumped Amazon Stock. Here Are 5 Reasons to Buy It.

You probably have different goals than Berkshire Hathaway....

Fool - Investing News - 5/31/2026 9:05:00 AM More News for AMZN
Stock Analysis for AMZN

Related Stocks:

Card image cap
Card image cap
Kimbell Royalty Partners: Permian Basin Acquisition Slightly Increases Its Oil Cut

Kimbell is making a $147 million Permian Basin acquisition of mineral and royalty interests, with the consideration roughly 30% cash and 70% equity. It expects forward-year production of 1,390 BOEPD (54% oil) from those assets. This adds around 9% to its oil production. Kimbell's unit count is increasing by approximately 6% from the deal, and its distributable cash flow may increase by around 1% per unit....

Seeking Alpha - 5/31/2026 10:03:32 AM More News for PGPHF
Stock Analysis for PGPHF

Related Stocks:

Canadian Solar: Booming E-Storage-Driven Growth

Canadian Solar is rated Buy, driven by a booming e-STORAGE business with a record $3.5B contracted backlog. CSIQ's e-STORAGE revenue is set to accelerate, with shipment guidance raised to 4.5–5.5 GWh in FY2026 and strong growth projected through 2027. Consensus expects CSIQ to return to profitability in FY2027, with EPS reaching $0.98 and revenue growth of 25.76% YoY....

Seeking Alpha - 5/31/2026 10:02:36 AM More News for CSIQ
Stock Analysis for CSIQ

Related Stocks:

Card image cap
Card image cap
All missing victims recovered in Washington paper mill explosion

The remains of all missing victims in a Washington state paper mill explosion have been recovered, officials announced Saturday.“Today, on day five of this incident, I can share that we have recovered the ninth and final missing employee of this incident,” Longview Fire Chief Brad Hannig said in a Saturday news conference....

NBC News - 5/31/2026 2:03:00 AM More News for
Stock Analysis for

Related Stocks:

Could Buying Rocket Lab Stock Today Set You Up for Life?

Its backlog has grown to over $2 billion as it positions itself as an end-to-end space company. The company's revenue is steadily climbing and reached $200 million in this year's first quarter....

The Motley Fool - 5/31/2026 9:30:00 AM More News for RKLB
Stock Analysis for RKLB

Related Stocks:

Card image cap
Card image cap
Trump in excellent health with leg swelling and hand bruising, doctor says

Memo on US president's health released after physical earlier in the week; leg swelling continues but has improved, memo says; Trump turns 80 in June...

The Times of Israel - 5/31/2026 1:55:32 AM More News for
Stock Analysis for

Related Stocks:

How to Build a Summer Retirement Income Plan Before the Markets Move

Summer is often a slow time on Wall Street, as investors take time off for family and vacations.  If you are planning some summer fun, here's a simple formula for generating dividends that requires little attention....

The Motley Fool - 5/31/2026 9:15:00 AM More News for DIVO
Stock Analysis for DIVO

Related Stocks:

Card image cap
Card image cap
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where...

GuruFocus - 5/31/2026 9:00:00 AM More News for JNJ
Stock Analysis for JNJ

Related Stocks:

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri Test Substantially Increased Cancer Detection With R...

GuruFocus - 5/31/2026 9:00:00 AM More News for GRAL
Stock Analysis for GRAL

Related Stocks:

Card image cap
Card image cap
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm

Johnson and Johnson's Phase 3 prostate cancer study shows ERLEADAÂ (apalutamide) before and after surgery significantly reduces risk of metastas...

GuruFocus - 5/31/2026 9:00:00 AM More News for APA
Stock Analysis for APA

Related Stocks:

The Muni Brief: NYC's Pied-à-Terre Tax

Welcome to The Muni Brief, a series on municipal credit and markets. In each installment, Senior Municipal Strategist James Colby examines current events, policy developments, and fiscal trends through the lens of the muni investor — covering topics both local and national....

ETF Trends - 5/31/2026 9:36:59 AM More News for NYC
Stock Analysis for NYC

Related Stocks:

Card image cap
Card image cap
‘Love Island USA’ Cast Member Dismissed Ahead Of Season 8 After Videos Surface Of Contestant Using Racial Slur

A Love Island USA cast member has been dismissed from the reality dating show just days ahead of its eighth season premiere following resurfaced videos in which the contestant used a racial slur. Vasa......

Yahoo - 5/31/2026 12:22:00 AM More News for
Stock Analysis for

Related Stocks:

Silicom: The Market Is Still Pricing In A Cycle That Already Ended

Silicom Ltd. is rated buy, trading at a steep 2.36x NTM revenue versus a 9.51x peer median, despite five quarters of sequential growth. SILC's design-win model, R&D intensity, and expanding edge/security use cases drive recurring revenue and create structural switching costs. Three macro tailwinds—AI inference, post-quantum cryptography, and white-label switches—support a bottom-line recovery and offer material upside optionality....

Seeking Alpha - 5/31/2026 9:25:55 AM More News for SILC
Stock Analysis for SILC

Related Stocks:

Card image cap
Card image cap
Trump Urges Canceling Freedom 250 Concerts After Artists Drop Out

The president had earlier said on social media that he should take the place of “these highly paid, Third Rate ‘Artists,’” saying he gets “larger audiences than Elvis.”...

The New York Times - 5/31/2026 1:14:45 AM More News for
Stock Analysis for

Related Stocks:

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen Has A Cleaner Recovery Angle, But With High Valuation...

Seeking Alpha - 5/31/2026 9:15:00 AM More News for RGEN
Stock Analysis for RGEN

Related Stocks:

Card image cap
Card image cap
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China

MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and sponsored by Summit's partner Akeso, Inc. (HKEX Code: 9926.HK), will be presented today as part of the Plenary Session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The presentation is entitled “Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in previously untrea....

Business Wire - 5/31/2026 9:06:00 AM More News for SMMT
Stock Analysis for SMMT

Related Stocks:

Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer

IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR of 8....

Globe News Wire - 5/31/2026 9:00:00 AM More News for IMTX
Stock Analysis for IMTX

Related Stocks:

Card image cap
Card image cap
The Hidden Cost of Large IRA Withdrawals: How $50,000 Can Cost You $6,200 in Taxes

The Moment Many Retirees Don't See Coming A 70-year-old living on $30,000 in Social Security has been getting by on a tight budget for years. The car needs replacing, the roof is leaking, and the traditional IRA has been sitting there untouched. Pulling out $50,000 to cover the year's big expenses feels reasonable. Then the... The Hidden Cost of Large IRA Withdrawals: How $50,000 Can Cost You $6,200 in Taxes...

247 Wallst - 5/31/2026 8:45:27 AM More News for
Stock Analysis for

Related Stocks:

2 Space Stocks to Buy Before the SpaceX IPO on June 12

The SpaceX IPO is putting the focus on the massive opportunity in space, and these two stocks stand to benefit....

Fool - Investing News - 5/31/2026 8:45:00 AM More News for ASTS
Stock Analysis for ASTS

Related Stocks:

Card image cap
Card image cap
NUAI FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages New Era Energy & Digital, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - NUAI

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of New Era Energy & Digital, Inc. (NASDAQ: NUAI) between November 6, 2024 and December 29, 2025, inclusive (the "Class Period"), of the important June 1, 2026 lead plaintiff deadline. SO WHAT: If you purchased New Era Energy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....

Newsfile Corp - 5/31/2026 9:11:00 AM More News for NUAI
Stock Analysis for NUAI

Related Stocks:

ePlus: Take Note Of High Growth Concentration

ePlus inc. ended FY2026 on a strong note. Fourth quarter revenues grew well, which ePlus managed to turn into increased earnings. AI seems to be a tailwind on PLUS's growth going forward, as customers are investing in AI capabilities. There's reason to be cautious. PLUS's FY2026 growth seems to have been achieved due to a few outsized projects, which may not be replicated....

Seeking Alpha - 5/31/2026 9:08:22 AM More News for PLUS
Stock Analysis for PLUS

Related Stocks:

Card image cap
Card image cap
Vicor: Mid-Quarter Guidance Raise Confirms The IP Thesis (Rating Upgrade)

Vicor: Mid-Quarter Guidance Raise Confirms The IP Thesis (Rating Upgrade)...

Seeking Alpha - 5/31/2026 9:06:00 AM More News for VICR
Stock Analysis for VICR

Related Stocks:

IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Immutep To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Immutep between March 24, 2025 and March 12, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - May 31, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP) and reminds investors of the July 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company....

Newsfile Corp - 5/31/2026 9:04:00 AM More News for IMMP
Stock Analysis for IMMP

Related Stocks:

Card image cap
Card image cap
QDVO: This Tactical Covered Call ETF Continues Delivering Double Digit Yields

Amplify CWP Growth & Income ETF delivers a double-digit yield and equity appreciation, outperforming SPY since inception with a 44.68% total return. QDVO's tactical covered call strategy on a concentrated large-cap growth portfolio enables participation in rallies while generating recurring income. Technology exposure exceeds 40%, with the Magnificent Seven comprising 64% of assets, targeting both high option premiums and growth....

Seeking Alpha - 5/31/2026 9:00:00 AM More News for QDVO
Stock Analysis for QDVO

Related Stocks:

Loud noise heard throughout Southern New England

A loud noise caused by a meteor was heard throughout Rhode Island and Massachusetts at around 2:10 on Saturday afternoon....

WJAR - 5/31/2026 12:56:17 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Microsoft: This Price Makes No Sense

Microsoft offers significant upside, with robust growth drivers from AI partnerships and cloud expansion, making current valuations highly attractive. Partnership with Anthropic could generate up to $43 billion in annual revenue by 2030, boosting MSFT's AI and cloud prospects. Accelerated AI data center deployment and Copilot's shift to usage-based pricing are set to drive recurring revenue and margin expansion for MSFT....

Seeking Alpha - 5/31/2026 9:00:00 AM More News for MSFT
Stock Analysis for MSFT

Related Stocks:

BitFuFu: A Buy Is Becoming Difficult To Justify (Rating Downgrade)

BitFuFu is downgraded to Hold after Q1 FY26 results reveal persistent tight margins. FUFU's dual-engine model hedges revenue volatility, with cloud mining now 79% of revenue, but cost structure remains burdened by related-party hosting fees. Operational efficiency improved: hashrate under management rose 25.7% YoY while power capacity fell, yet gross margin stayed minimal at 0.51%....

Seeking Alpha - 5/31/2026 9:00:00 AM More News for FUFU
Stock Analysis for FUFU

Related Stocks:

Card image cap
Card image cap
Intellia Therapeutics - Steady Progress, Historic Commercial Approval In Sight

Intellia Therapeutics remains a Buy, driven by two pivotal in vivo gene therapy catalysts: Lonvo-Z for HAE and Nex-Z for ATTR amyloidosis. Lonvo-Z's Phase 3 data met all endpoints with an 87% attack reduction, but market reaction was muted due to safety concerns and the competitive landscape. The FDA lifted clinical holds on Nex-Z Phase 3 trials, enabling advancement in a $16.8bn ATTR market with a differentiated one-time treatment profile....

Seeking Alpha - 5/31/2026 8:45:00 AM More News for NTLA
Stock Analysis for NTLA

Related Stocks:

IUSV: VLUE And FVAL May Be More Compelling

The iShares Core S&P U.S. Value ETF offers broad, diversified exposure to U.S. value equities with a low 0.04% expense ratio. IUSV's long-term returns and volatility closely match the Russell 1000 benchmark, but recent performance lags, with a 6% shortfall over the past year. Competitors VLUE and FVAL have outperformed IUSV since 2016, aided by cash-flow-based valuation and sector-specific methodologies....

Seeking Alpha - 5/31/2026 8:37:59 AM More News for IUSV
Stock Analysis for IUSV

Related Stocks:

Card image cap
Card image cap
5 Under-the-Radar AI Stocks to Watch in June

Believe it or not, June is here, and with it the summer trading season. That means lower trading volumes, potential for volatility, and opportunities for savvy traders....

MarketBeat - 5/31/2026 8:36:20 AM More News for AIRJ
Stock Analysis for AIRJ

Related Stocks:

ROSEN, SKILLED INVESTOR COUNSEL, Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW

New York, New York--(Newsfile Corp. - May 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of DNOW Inc. (NYSE: DNOW) resulting from allegations that DNOW may have issued materially misleading business information to the investing public. SO WHAT: If you purchased DNOW securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement....

Newsfile Corp - 5/31/2026 8:32:00 AM More News for DNOW
Stock Analysis for DNOW

Related Stocks:

Card image cap
Card image cap
Hormel Foods' Dividend Yield Is Attractive As Profits Stabilize (Rating Upgrade)

Hormel Foods Corporation reported positive Q2 results. Input cost inflation has weighed on HRL's margins, but retail segment earnings are finally stabilized in the report. A stabilizing earnings outlook makes HRL's dividend yield safer and more attractive....

Seeking Alpha - 5/31/2026 8:30:00 AM More News for HRL
Stock Analysis for HRL

Related Stocks:

Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the next-generation of Lens, its pioneering agentic AI platform designed to accelerate drug development and research. This evolution seamlessly connects Tempus' multimodal data, AI tooling and computational infrastructure to deliver actionable insights at the pace required for drug development. The next-generation of the Lens platf....

Business Wire - 5/31/2026 8:30:00 AM More News for TEM
Stock Analysis for TEM

Related Stocks:

Card image cap
Card image cap
SoftBank plans 75 billion euros of AI investments in France, as Europe struggles to catch up with U.S. and China

Japan's Softbank is planning to invest 45 billion euros ($53 billion) over five years to build AI infrastructure in France in the first phase of its push. The commitment is part of a 75-billion-euro ($87 billion) program by Softbank to build AI data centers in France...

CNBC - 5/31/2026 8:09:54 AM More News for SOBKY
Stock Analysis for SOBKY

Related Stocks:

Are Micron and Sandisk Stocks in a Bubble?

Sandisk and Micron are both memory chip producers. Both companies are seeing rapid growth....

The Motley Fool - 5/31/2026 8:08:00 AM More News for MU
Stock Analysis for MU

Related Stocks:

Card image cap
Card image cap
Graham Platner’s wife says she’s ‘deeply hurt’ by public revelations of her husband’s extramarital sexts

The wife of Maine Democratic Senate candidate Graham Platner said she was “deeply hurt” after details of her husband’s extramarital sexting became public Saturday, accusing a former campaign official and confidante of betraying her trust....

CNN - 5/31/2026 12:28:00 AM More News for
Stock Analysis for

Related Stocks:

S&P 500 Dividend Yield Hits 1.08%. The Lowest Payout Rate Since the 1800s Is a Retirement Red Flag.

The S&P 500 dividend yield has fallen to 1.08%, a level the index has not seen since the 1800s....

24/7 Wall Street - 5/31/2026 8:26:47 AM More News for SPY
Stock Analysis for SPY

Related Stocks:

Card image cap
Card image cap
Longview officials recover and identify all nine missing in Nippon mill tank implosion

Officials in Longview, Washington, said Saturday afternoon that all nine workers who were missing after a white liquor tank implosion at a paper mill....

KATU - 5/31/2026 12:11:03 AM More News for
Stock Analysis for

Related Stocks:

The Credit Card Mistake That's Cost My Parents Thousands

My parents have one credit card

and they only use it for one thing. Here's what that's cost them, and the one additional card that could save them a ton....

Fool - Investing News - 5/31/2026 8:05:03 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
How Much Does the Typical Gen Xer Have Saved for Retirement?

Your age affects how much you have saved for retirement. See where you stand relative to the typical Gen Xer....

Fool - Investing News - 5/31/2026 7:50:00 AM More News for
Stock Analysis for

Related Stocks:

Is the Market Setting Up for a Summer Rally or a Summer Slump?

The S&P 500 is up nearly 10% year to date....

Fool - Investing News - 5/31/2026 7:44:00 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
SoundHound AI's Stock Price Is Down 29% in the Last 6 Months -- Here's Why It Still Could Be a Long-Term Buy

That slump won't be instantly reversed, but SoundHound AI still has long-term potential....

Fool - Investing News - 5/31/2026 7:33:00 AM More News for SOUN
Stock Analysis for SOUN

Related Stocks:

Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial

An experimental drug developed ​by China-based Akeso helped patients with advanced squamous non-small cell lung cancer live 15% longer than BeOne Medicines' immunotherapy Tevimbra, ‌and cut the risk of death by more than one-third in a study presented at a medical meeting on Sunday....

Reuters - 5/31/2026 8:03:54 AM More News for AKESF
Stock Analysis for AKESF

Related Stocks:

Card image cap
Card image cap
J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

Johnson & Johnson's ​prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances ‌of eliminating the cancer and reduced the risk of disease progression or death, according to data from a late-stage trial presented on Sunday....

Reuters - 5/31/2026 8:01:58 AM More News for JNJ
Stock Analysis for JNJ

Related Stocks:

How Poland Became Europe's Growth Leader

Poland has become one of Europe's standout growth stories, with an economy that crossed $1 trillion and a new generation of entrepreneurs returning home after studying and working abroad. Finance Minister Andrzej Domański points to decades of reform, EU integration, foreign investment and a diversified economy as drivers of Poland's rise, while venture capitalist Aleksandra Pedraszewska says Warsaw's technology scene now offers opportunities that were far less obvious a decade ago....

Bloomberg Markets and Finance - 5/31/2026 8:00:12 AM More News for EPOL
Stock Analysis for EPOL

Related Stocks:

Card image cap
Card image cap
NJ Gov. Sherrill blames outsiders for Delaney Hall protest violence

The governor said most of those arrested in a weekend clash were from outside New Jersey....

Gothamist - 5/31/2026 12:03:00 AM More News for
Stock Analysis for

Related Stocks:

A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China

An experimental lung cancer drug from Akeso and Summit Therapeutics improved survival in the Harmoni-6 Phase 3 trial conducted in China, according to results being presented at the American Society of Clinical Oncology annual meeting. Called ivonescimab, the bispecific antibody targets PD-1 — similar to Merck's best-selling drug Keytruda — and VEGF — similar to Roche's Avastin....

CNBC - 5/31/2026 8:00:02 AM More News for SMMT
Stock Analysis for SMMT

Related Stocks:

Card image cap
Card image cap
Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) versus FOLFIRI with or without bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. These results will be....

Business Wire - 5/31/2026 8:00:00 AM More News for PFE
Stock Analysis for PFE

Related Stocks:

Anti-AI Investing: The HALO Moat

I focus on HALO investing: Heavy Assets, Low Obsolescence - owning irreplaceable physical assets with durable moats against technological disruption. Top recommendations include American Tower, Brookfield Infrastructure, Prologis, Rexford Industrial, Lineage, Americold, VICI Properties, and Lamar Advertising. AMT, COLD, and VICI currently offer attractive entry points based on discounted multiples, robust dividend yields, and resilient, monopoly-like asset bases....

Seeking Alpha - 5/31/2026 8:00:00 AM More News for HALO
Stock Analysis for HALO

Related Stocks:

Card image cap
Card image cap
Marsh & McLennan: 16 Years Of Dividend Growth And Counting

Marsh & McLennan is delivering robust organic revenue growth, strong EPS beats and maintains a compelling dividend profile amid sector headwinds. MRSH trades at a forward P/E of 14.9, well below its 10-year average of 21.9, presenting a 26% discount to fair value. With an A- S&P rating, MRSH is positioned for continued bolt-on acquisitions and sustained dividend growth, targeting at least 9% annual increases....

Seeking Alpha - 5/31/2026 8:00:00 AM More News for MRSH
Stock Analysis for MRSH

Related Stocks:

Why VICI Properties Is My Default Buy At Current Prices

VICI Properties has stable cash flows, disciplined growth, and an undervalued 9.6x forward P/FFO multiple. VICI's 100% triple-net lease structure, 100% occupancy, and strong tenant guarantees underpin resilient income and a well-covered 6.4% dividend yield. Recent accretive acquisitions and self-funded investments drive 4.5% AFFO/share growth, supported by a conservative 5.0x net debt/EBITDA balance sheet....

Seeking Alpha - 5/31/2026 8:00:00 AM More News for VICI
Stock Analysis for VICI

Related Stocks:

Card image cap
Card image cap
Inside Trump’s Deal With the I.R.S. to Drop His $10 Billion Lawsuit

Discussions among a group of lawyers with allegiance to the president were closely held. Some senior White House officials were said to have felt blindsided as the agreement took shape....

The New York Times - 5/30/2026 11:47:18 PM More News for
Stock Analysis for

Related Stocks:

President Trump attacks "jealous" critics of Jaxson Dart

Just when the Giants thought they were out of the Jaxson Dart-Donald Trump conundrum, Trump pulled them back in....

NBC Sports - 5/30/2026 11:40:44 PM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Here's How Much Traders Expect Palo Alto Networks Stock to Move After Earnings

Palo Alto Networks is set to report its latest quarterly earnings after the closing bell Tuesday, with traders expecting a sizable move in the cybersecurity stock that could push it to new highs....

Investopedia - 5/31/2026 7:50:47 AM More News for PANW
Stock Analysis for PANW

Related Stocks:

Maybe the light rail system we’ve got is good enough

Light rail is finally cooking in the Seattle area. It coincides with an existential crisis over building expansion lines for the future. At what point do we say "it's good,"......

The Seattle Times - 5/30/2026 11:28:48 PM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Oil Be Buying: My Absolute Favorite Energy Stocks

Energy remains a top investment focus due to global demand, constrained supply growth, and attractive sector valuations versus the S&P 500. I highlight my preferred picks across the energy supply chain: LandBridge, Viper Energy, Helmerich & Payne, Diamondback Energy, Western Midstream, and Marathon Petroleum. VNOM offers high cash returns to shareholders, while WES and MPC provide strong yields and capital return strategies, each excelling in their respective niches....

Seeking Alpha - 5/31/2026 7:30:00 AM More News for VNOM
Stock Analysis for VNOM

Related Stocks:

SCHG: Making New Highs And I Still Think It's A Long-Term Buy

Schwab US Large-Cap Growth ETF offers low-cost, tax-efficient exposure to leading growth companies, with a strong tilt toward technology and AI leaders. SCHG's top holdings—NVDA, AAPL, and MSFT—anchor its portfolio, benefiting from robust AI adoption and projected double-digit growth rates. Despite trading near 52-week highs and short-term valuation risks, SCHG remains a buy for long-term investors seeking growth at minimal cost....

Seeking Alpha - 5/31/2026 7:30:00 AM More News for SCHG
Stock Analysis for SCHG

Related Stocks:

Card image cap
Card image cap
Experimental Novartis radiopharma drug shows promise in early study

Novartis said on Sunday that early data from ‌its experimental actinium-based drug showed signs of anti-tumour activity against prostate cancer, including in patients previously treated with its older drug Pluvicto....

Reuters - 5/31/2026 7:16:57 AM More News for NVS
Stock Analysis for NVS

Related Stocks:

Jensen Huang Just Called Humanoid Robots a $40 Trillion Market. Here's Why Wall Street Is Loading Up on Physical AI Stocks

Jensen Huang has spent the past year repeating one number that keeps growing louder: humanoid robots represent a $40 trillion total addressable market for labor automation....

24/7 Wall Street - 5/31/2026 7:20:57 AM More News for NVDA
Stock Analysis for NVDA

Related Stocks:

Card image cap
Card image cap
If Rates Fall Further, Here's What Happens to the KRE Regional Banking ETF

The SPDR S&P Regional Banking ETF (NYSEARCA:KRE | KRE Price Prediction) has quietly become one of 2026's better-performing financial trades, rising roughly 9% year to date and 28% over the past year to around $70 a share....

24/7 Wall Street - 5/31/2026 7:18:33 AM More News for KRE
Stock Analysis for KRE

Related Stocks:

42 Months of 0% Intro APR: Is a Double Balance Transfer Right for You?

A double balance transfer, using two balance transfer cards back to back, could get you 42 months of 0% interest

theoretically. Here's what to know....

Fool - Investing News - 5/31/2026 7:10:37 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Apple's AI Future, Stock Surge, Nvidia CEO's New Role And More: This Week In Appleverse

Apple's AI-driven "agentic smartphone" narrative, stock surge, and Nvidia CEO's advisory role highlight major shifts in tech leadership....

Benzinga - 5/31/2026 7:01:02 AM More News for
Stock Analysis for

Related Stocks:

A $600,000 Annuity Pays $3,700 a Month for Life. What About Your Spouse?

A 65-year-old retiree walks into a meeting with $600,000 in an IRA and walks out with a pitch. Hand it over to an insurance company today, and a single-premium immediate annuity (SPIA) will pay $3,700 a month for life. That is $44,400 a year, guaranteed, with no market risk and no decisions to make ever... A $600,000 Annuity Pays $3,700 a Month for Life. What About Your Spouse?...

247 Wallst - 5/31/2026 6:52:26 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Exxon and Chevron Are Warning That Oil Prices Could Skyrocket in the Coming Weeks. Here's What That Could Mean for Investors.

The oil market is approaching a danger zone....

Fool - Investing News - 5/31/2026 6:45:00 AM More News for XOM
Stock Analysis for XOM

Related Stocks:

The Social Security Rule Working Retirees Need to Watch Closely in 2026

Not paying attention could lead to an unwanted surprise....

Fool - Investing News - 5/31/2026 6:36:00 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
How $500,000 in Life Insurance Can Earn $18,000 to $19,000 Annually While You Grieve and Decide

Two weeks after her 52-year-old husband died unexpectedly, a 54-year-old woman called Suze Orman's podcast with the question hundreds of recent widows wrestle with every month: what do I do with the life insurance check? In her case, the payout sat alongside a 401(k) and an IRA, and she wanted to know whether to invest... How $500,000 in Life Insurance Can Earn $18,000 to $19,000 Annually While You Grieve and Decide...

247 Wallst - 5/31/2026 6:30:34 AM More News for
Stock Analysis for

Related Stocks:

45.7% of Berkshire Hathaway's Portfolio Is Parked in 3 Stocks That Could Pay the Conglomerate $1.6 Billion in Dividends This Year

Berkshire uses dividends to fund further investments, which supercharges its returns....

Fool - Investing News - 5/31/2026 6:30:00 AM More News for AAPL
Stock Analysis for AAPL

Related Stocks:

Card image cap
Card image cap
Social Security Gets Taxed When Dividends Cross This Threshold. Most Retirees Miss It

When a Comfortable Dividend Stream Turns Into a Tax Surprise Picture a single retiree drawing $30,000 a year in Social Security and another $50,000 from a taxable brokerage account stuffed with dividend payers. On paper, it looks like a clean $80,000 retirement: steady, diversified, mostly passive. Then the first full tax return after building that... Social Security Gets Taxed When Dividends Cross This Threshold. Most Retirees Miss It...

247 Wallst - 5/31/2026 6:20:51 AM More News for
Stock Analysis for

Related Stocks:

Dell Delivers On AI Infrastructure Demand

Dell Technologies reported a robust Q1'27 beat, driven by strong AI-optimized and traditional server demand and commercial client growth. AI-optimized server backlog surged to $51.3B, and commercial client compute grew 18% YoY, supporting expectations for continued growth and margin improvement. I am reiterating my Buy rating on DELL and raising the price target to $482/share, reflecting confidence in sustained operational momentum....

Seeking Alpha - 5/31/2026 7:06:23 AM More News for DELL
Stock Analysis for DELL

Related Stocks:

Card image cap
Card image cap
UFO: Time To Consider Selling The Space Stock Rally (Downgrade)

The Procure Space ETF has surged 163% over the past 12 months, driven by sector momentum and anticipation of the SpaceX IPO. UFO's portfolio is concentrated but includes holdings like Sirius XM and Trimble which may not fully capture the speculative upside from the SpaceX catalyst. Some other sector ETFs offer more direct exposure to pureplay space companies and even SpaceX itself....

Seeking Alpha - 5/31/2026 7:00:00 AM More News for UFO
Stock Analysis for UFO

Related Stocks:

Frankie Valli cancels remainder of Four Seasons’ farewell tour

Frankie Valli, whose legendary falsetto defines the sound of the 1960s rock group the Four Seasons, has cancelled the remainder of the band’s 2026 tour dates...

ABC News - Breaking News, Latest News and Videos - 5/30/2026 10:54:55 PM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Graham Platner sent explicit texts to other women during marriage, wife confirms

Amy Gertner, wife of Democratic Senate candidate in Maine, says she is ‘hurt’ ex-political director exposed texts...

The Guardian - 5/30/2026 10:49:00 PM More News for
Stock Analysis for

Related Stocks:

Darren Till demolishes Aaron Chalmers with brutal one-punch knockout after surviving knockdown in BKFC debut

Darren Till survived an early scare and then delivered a brutal knockout in his bare-knuckle debut....

MMA Fighting - 5/30/2026 10:38:50 PM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
After Following Generative AI Every Single Day These 3 ETFs Keep Rising to the Top of My Research

Tracking generative AI as a daily beat means watching dozens of funds slap the “AI” label on portfolios that look suspiciously like a Nasdaq-100 mirror....

24/7 Wall Street - 5/31/2026 6:41:50 AM More News for CHAT
Stock Analysis for CHAT

Related Stocks:

Longest 0% Intro APR Credit Cards This Week, May 31, 2026: Take Back Control Before Summer

Get up to 24 months with 0% intro APR on this week's top offers. Stop losing money to interest and start making real headway on your balance....

Fool - Investing News - 5/31/2026 6:32:34 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Get 4.10% APY for a Limited Time: Best Bank Account Bonuses This Week, May 31, 2026

This high-yield savings account is offering a strong 4.10% APY for your first six months when you use a promo code. Here's what to know and how to earn it today....

Fool - Investing News - 5/31/2026 6:32:33 AM More News for
Stock Analysis for

Related Stocks:

How to Decide if a Credit Card's Annual Fee Is Worth It

Here's a practical framework for deciding if a credit card's annual fee pays off, plus a personal take on running the real math before applying....

Fool - Investing News - 5/31/2026 6:32:31 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
The Only Tech Stock I'd Buy If I Could Only Pick One Right Now

This stock gives you exposure to growth in artificial intelligence (AI), space, and more....

Fool - Investing News - 5/31/2026 6:15:00 AM More News for AMZN
Stock Analysis for AMZN

Related Stocks:

The Stock Market Is Doing Something That's Virtually Unprecedented -- and History Shows There's No Mistaking What Comes Next

This has only been witnessed one other time since the early 1870s....

Fool - Investing News - 5/31/2026 6:06:00 AM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Could Nvidia Reach Another All-Time High? Analysts Are Watching One Key Number

Nvidia stock has pulled back followings its Q1 report. What comes next?...

Fool - Investing News - 5/31/2026 5:45:00 AM More News for NVDA
Stock Analysis for NVDA

Related Stocks:

NTSB says high rate of speed factored into deadly I

The NTSB said it appeared that a high rate of speed played a role in a bus crashing into six vehicles Friday on Interstate 95 in Virginia, killing five and injuring dozens....

WTOP - 5/30/2026 10:36:06 PM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Morgan Wallen Flips Piano Onstage After Technical Issue, Video

Morgan Wallen's song "180" might as well have described his piano last night ... because he nearly flipped the thing completely over mid-show!...

TMZ - 5/30/2026 10:30:14 PM More News for
Stock Analysis for

Related Stocks:

Search for man believed to be “Alaskan Bush People”'s Matt Brown suspended after reports that he took his own life

Authorities halted their investigation due to "dangerous river conditions" and to focus their efforts after Brown's brother said he fears he is dead....

Yahoo - 5/30/2026 10:24:51 PM More News for
Stock Analysis for

Related Stocks:

Card image cap
Card image cap
Molson Coors: Deeply Undervalued While Offering A Double-Digit Yield (Upgrade)

Molson Coors Beverage Company is upgraded to Strong Buy, as the valuation disconnect widens despite solid fundamentals and recovery potential. TAP maintains robust cash flow and a healthy balance sheet and offers a potential double-digit combined dividend-plus-buyback yield, which is covered by the underlying free cash flow. Management targets $450 million in cost savings by 2029, network modernization, and premiumization to offset macro and competitive pressures....

Seeking Alpha - 5/31/2026 6:25:16 AM More News for TAP
Stock Analysis for TAP

Related Stocks:

Interest Rate Forecast: Dow Jones and S&P 500 Rally Despite Fed Rate Risks

Higher inflation, oil volatility, and mixed growth signals keep the Fed under pressure as markets price a higher-for-longer interest rate outlook, with Treasury yields, the U.S. dollar, and major stock indices reacting to shifting rate expectations....

FXEmpire - 5/31/2026 6:16:23 AM More News for DOW
Stock Analysis for DOW

Related Stocks:

Card image cap
Settings
Color Scheme

Left Sidebar